iTonic Holdings Ltd Class A Ordinary Shares (ITOC)

Price$0.32

Favorite Metrics

Price vs S&P 500 (26W)-63.40%

Price vs S&P 500 (4W)6.77%

Market Capitalization$5.41M

All Metrics

Revenue Growth (3Y)-13.92%

Price vs S&P 500 (YTD)-28.71%

Gross Margin (TTM)82.86%

Net Profit Margin (TTM)-790.56%

EPS (TTM)$-0.16

10-Day Avg Trading Volume0.17M

EPS Excl Extra (TTM)$-0.16

EPS (Annual)$-0.05

ROI (Annual)-10.27%

Gross Margin (Annual)85.04%

Cash / Share (Quarterly)$0.19

Revenue Growth QoQ (YoY)-67.93%

ROA (Last FY)-9.83%

Revenue Growth TTM (YoY)-32.45%

EBITD / Share (TTM)$-0.17

Operating Margin (TTM)-831.05%

Cash Flow / Share (Annual)$-0.05

P/B Ratio1.14x

Net Income / Employee (Annual)$-0

ROA (TTM)-40.77%

EPS Incl Extra (Annual)$-0.05

Current Ratio (Annual)12.40x

Quick Ratio (Quarterly)8.96x

3-Month Avg Trading Volume2.62M

52-Week Price Return-88.98%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)12.07x

Asset Turnover (Annual)0.07x

52-Week High$32.00

EPS Excl Extra (Annual)$-0.05

26-Week Price Return-54.66%

Quick Ratio (Annual)12.10x

13-Week Price Return-27.83%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)11.69x

Asset Turnover (TTM)0.05x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)0.79x

Pretax Margin (Annual)-142.52%

Cash / Share (Annual)$0.43

3-Month Return Std Dev251.58%

Net Income / Employee (TTM)$-0

ROE (Last FY)-10.68%

EPS Basic Excl Extra (Annual)$-0.05

Receivables Turnover (TTM)2.02x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-0.16

Receivables Turnover (Annual)1.84x

ROI (TTM)-42.69%

P/S Ratio (TTM)17.73x

Revenue / Share (Annual)$0.04

Price vs S&P 500 (52W)-124.07%

Year-to-Date Return-24.57%

5-Day Price Return12.95%

EPS Normalized (Annual)$-0.05

Net Profit Margin (Annual)-147.39%

Month-to-Date Return-9.31%

EBITD / Share (Annual)$-0.04

Operating Margin (Annual)-171.86%

EPS Basic Excl Extra (TTM)$-0.16

Inventory Turnover (TTM)0.63x

Pretax Margin (TTM)-777.35%

Price vs S&P 500 (13W)-30.70%

Beta2.55x

P/FCF (Annual)67.00x

Revenue / Share (TTM)$0.02

ROE (TTM)-44.21%

52-Week Low$0.25

About

iTonic Holdings Ltd provides treatment planning systems for brachytherapy, a targeted radiation therapy for cancer treatment. Its Beijing Feitian system enables precise delivery of radioactive sources to maximize treatment efficacy while minimizing patient risk.